Transplantation Market to Exhibit a CAGR of 10.6% by 2028; Rising Incidence of Cancer and Kidney Failure to Fuel Demand for Transplantations: Fortune Business Insights™

The global “transplantation market” size is expected to reach USD 14.67 billion by 2028, exhibiting a CAGR of 10.6% during the forecast period. The increasing awareness regarding organ donations coupled with government initiatives can have an excellent impact on the global market in the forthcoming years, states Fortune Business Insights, in a report, titled “Transplantation Market, 2021-2028.” The market size stood at USD 5.47 billion in 2020.

An Overview of the Impact of COVID-19 on this Market

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Acquisition of Hawaii Cellular Therapy and Transplant Laboratory (HCTTL) by Eurofins Transplant Diagnostics to Aid Development

Eurofins' US Transplant Diagnostics announced the successful acquisition of the Hawaii Cellular Therapy and Transplant Laboratory (HCTTL). HCTTL signed an agreement with Eurofins VRL to enlarge VRL's substantial US geographic footprint. Moreover, the acquisition will improve the long-standing pillar of the Hawaiian transplant community and increase VRL's network of laboratories that are now located in 11 states. It will serve Organ Procurement Organizations, Tissue Banks, and commercial companies needing testing donated biological materials. The merger is expected to push this market's growth due to the transplant network and Eurofins Transplant Diagnostics’ strategies to strengthen its position in the transplantation market. The joint transplant diagnostics portfolio of Viracor-Eurofins laboratory and Transplant Genomics innovative testing of subclinical rejection detection testing will advance Eurofins' US Transplant Diagnostics and transplant care.

Request a Sample Copy of the Research Report

Increasing Cases of Chronic Diseases to Aid Development

The surging cases of chronic diseases such as cancer, kidney failure, COPD, lupus, and others will spur the market's opportunities in the foreseeable future. According to the American Lung Association, over 9 million adults over than age of 18 suffered from chronic bronchitis in the U.S in the year 2018, with over 200,000 new cases of lung cancer was recorded in the U.S. Furthermore, the increasing number of cases of organ failures has surged the demand for transplant procedures, which, in turn, will aid the growth of the market. According to the American Journal of Lung Transplantation the number of lung transplant surgeries in the U.S reached record high of more than 200 in the year 2017. There was an increase of 133 lung transplants from the previous year.

Quick Buy Transplantation Market

The Hospital Segment to Hold a Significant Share

Based on product type, the market is classified into tissue products, immunosuppressive drugs, and preservation solutions. The tissue segment is expected to account for the largest due to the advent of new, improved outcomes, including Chondrofix Osteochondral Allograft, DeNovo NT Graft, DuraMatrix Collagen Dura Substitute Membrane.

Based on application, the market is divided into organ transplant and tissue transplant. The tissue transplant segment is expected to account for the highest transplantation market share in the market during the forecast period.

Based on end-users, the market is classified into hospitals, transplantation centers, and others. The hospital segment is expected to hold the lion’s share due to the more significant number of transplants in these facilities.

Geographically, the market is classified into North America, Asia Pacific, Europe, Latin America, and the Middle East, and Africa.

North America to Lead the Market

The market size in North America stood at USD 2.29 billion in 2020. The growth is attributable to the well-established healthcare infrastructure in the US.
Asia Pacific is expected to experience the highest CAGR due to the growing number of chronic diseases coupled with the rising geriatric populace.
Europe is expected to hold a significant share due to increasing R&D investments by companies.
Have Any Query? Ask Our Experts

R&D Investments by Companies to Push Development

The market is dominated by numerous companies operating in the market. Companies are focused on developing novel products to achieve effective transplant procedures. Besides, companies' adoption of various strategies such as partnerships, mergers, and acquisitions will influence growth in the region. For instance, in September 2020, CollPlant Biotechnologies announced the collaboration and expansion of United Therapeutics Corporation.

The Report Lists the Main Companies in this Market:

Novartis International AG (Basel, Switzerland)
AbbVie Inc. (Illinois, U.S)
Arthrex, Inc. (Florida, U.S)
Biolife Solutions (Washington, U.S)
Teva Pharmaceutical (Petah Tikva, Israel)
Veloxis Pharmaceuticals, Inc. (Denmark)
(California, U.S)
TransMedics, Inc. (Andover, MA)
Other Players
Segments Covered in the Report

By Product Type

Tissue Products
Immunosuppressive Drugs
Preservation Solutions
By Application

Organ Transplant
Tissue Transplant
By End-User

Hospitals
Transplantation Centers
Others
By Geography

North America
By Product Type
By Application
By End-User
By Country
USA (By Application)
Canada (By Application)
Europe
By Product Type
By Application
By End-User
By Country
UK (By Application)
Germany (By Application)
France (By Application)
Italy (By Application)
Spain (By Application)
Scandinavia (By Application)
Rest of Europe (By Application)
Asia Pacific
By Product Type
By Application
By End-User
By Country
Japan (By Application)
China (By Application)
India (By Application)
Australia (By Application)
Southeast Asia (By Application)
Rest of Asia Pacific (By Application)
Latin America
By Product Type
By Application
By End-User
By Country
Brazil (By Application)
Mexico (By Application)
Rest of Latin America (By Application)
Middle East & Africa
By Product Type
By Application
By End-User
By Country
GCC (By Application)
South Africa (By Application)
Rest of MEA (By Application)

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

LinkedIn | Twitter | Blogs

This release was published on openPR.